Overview Fundamentals API Earnings EOD API Sample Code Pricing

Medicenna Therapeutics Corp (MDNAF NASDAQ) stock market data APIs

$1.41 -0.15(-9.6%) as of July 12, 2024
Price chart is built with Anychart

Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops bizaxofusp (MDNA55), an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a masked bi-functional anti-PD1-IL2 Superkine for various solid tumors; and MDNA132, an IL-13 Superkine for various tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, inhibitors, antibodies, cytokines, or other Superkines Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.

Medicenna Therapeutics Corp Financial Data Overview

105 M
74 779 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MDNAF',
Type: 'Common Stock',
Name: 'Medicenna Therapeutics Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00HNJW330',
CIK: '1807983',
EmployerIdNumber: '',
FiscalYearEnd: 'March',
IPODate: '2001-08-27',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Medicenna Therapeutics Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -18 670 000
  • Earnings Per Share -0.17
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Medicenna Therapeutics Corp Earnings via APIs

  • Latest Release 2024-06-25
  • EPS/Forecast -0.04

Get Medicenna Therapeutics Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?